ID   GAS6_RAT                Reviewed;         674 AA.
AC   Q63772;
DT   07-JUN-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   24-JUL-2024, entry version 176.
DE   RecName: Full=Growth arrest-specific protein 6;
DE            Short=GAS-6;
DE   AltName: Full=AXL receptor tyrosine kinase ligand;
DE   AltName: Full=Growth-potentiating factor;
DE            Short=GPF;
DE   Flags: Precursor;
GN   Name=Gas6;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7890695; DOI=10.1074/jbc.270.11.5702;
RA   Nakano T., Higashino K., Kikuchi N., Kishino J., Nomura K., Fujita H.,
RA   Ohara O., Arita H.;
RT   "Vascular smooth muscle cell-derived, Gla-containing growth-potentiating
RT   factor for Ca(2+)-mobilizing growth factors.";
RL   J. Biol. Chem. 270:5702-5705(1995).
RN   [2]
RP   RECEPTOR INTERACTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=7559388; DOI=10.1074/jbc.270.39.22681;
RA   Ohashi K., Nagata K., Toshima J., Nakano T., Arita H., Tsuda H., Suzuki K.,
RA   Mizuno K.;
RT   "Stimulation of sky receptor tyrosine kinase by the product of growth
RT   arrest-specific gene 6.";
RL   J. Biol. Chem. 270:22681-22684(1995).
RN   [3]
RP   RECEPTOR INTERACTION.
RX   PubMed=8939948; DOI=10.1074/jbc.271.47.30022;
RA   Nagata K., Ohashi K., Nakano T., Arita H., Zong C., Hanafusa H., Mizuno K.;
RT   "Identification of the product of growth arrest-specific gene 6 as a common
RT   ligand for Axl, Sky, and Mer receptor tyrosine kinases.";
RL   J. Biol. Chem. 271:30022-30027(1996).
RN   [4]
RP   GAMMA-CARBOXYGLUTAMATION.
RX   PubMed=9163328; DOI=10.1042/bj3230387;
RA   Nakano T., Kawamoto K., Kishino J., Nomura K., Higashino K., Arita H.;
RT   "Requirement of gamma-carboxyglutamic acid residues for the biological
RT   activity of Gas6: contribution of endogenous Gas6 to the proliferation of
RT   vascular smooth muscle cells.";
RL   Biochem. J. 323:387-392(1997).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-609; SER-614; THR-617;
RP   THR-633 AND TYR-636, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=16641100; DOI=10.1073/pnas.0600895103;
RA   Hoffert J.D., Pisitkun T., Wang G., Shen R.-F., Knepper M.A.;
RT   "Quantitative phosphoproteomics of vasopressin-sensitive renal cells:
RT   regulation of aquaporin-2 phosphorylation at two sites.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:7159-7164(2006).
CC   -!- FUNCTION: Ligand for tyrosine-protein kinase receptors AXL, TYRO3 and
CC       MER whose signaling is implicated in cell growth and survival, cell
CC       adhesion and cell migration. GAS6/AXL signaling plays a role in various
CC       processes such as endothelial cell survival during acidification by
CC       preventing apoptosis, optimal cytokine signaling during human natural
CC       killer cell development, hepatic regeneration, gonadotropin-releasing
CC       hormone neuron survival and migration, platelet activation, or
CC       regulation of thrombotic responses (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Heterodimer and heterotetramer with AXL.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:7559388}.
CC   -!- TISSUE SPECIFICITY: Plasma. {ECO:0000269|PubMed:7559388}.
CC   -!- PTM: Gamma-carboxyglutamate residues are formed by vitamin K dependent
CC       carboxylation. These residues are essential for the binding of calcium
CC       (Probable). {ECO:0000305|PubMed:9163328}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D42148; BAA07719.1; -; mRNA.
DR   PIR; I55476; I55476.
DR   AlphaFoldDB; Q63772; -.
DR   SMR; Q63772; -.
DR   STRING; 10116.ENSRNOP00000024677; -.
DR   GlyCosmos; Q63772; 3 sites, No reported glycans.
DR   GlyGen; Q63772; 3 sites.
DR   iPTMnet; Q63772; -.
DR   PhosphoSitePlus; Q63772; -.
DR   PaxDb; 10116-ENSRNOP00000024677; -.
DR   Ensembl; ENSRNOT00000024677.7; ENSRNOP00000024677.4; ENSRNOG00000018233.7.
DR   Ensembl; ENSRNOT00055024677; ENSRNOP00055020159; ENSRNOG00055014374.
DR   Ensembl; ENSRNOT00060044923; ENSRNOP00060037264; ENSRNOG00060025940.
DR   Ensembl; ENSRNOT00065014577; ENSRNOP00065010908; ENSRNOG00065009131.
DR   UCSC; RGD:61913; rat.
DR   AGR; RGD:61913; -.
DR   RGD; 61913; Gas6.
DR   eggNOG; ENOG502QT2N; Eukaryota.
DR   GeneTree; ENSGT00940000161271; -.
DR   HOGENOM; CLU_026236_0_0_1; -.
DR   InParanoid; Q63772; -.
DR   OMA; YHGVGRV; -.
DR   PhylomeDB; Q63772; -.
DR   TreeFam; TF352157; -.
DR   Reactome; R-RNO-114608; Platelet degranulation.
DR   Reactome; R-RNO-159763; Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus.
DR   Reactome; R-RNO-159782; Removal of aminoterminal propeptides from gamma-carboxylated proteins.
DR   Reactome; R-RNO-202733; Cell surface interactions at the vascular wall.
DR   Reactome; R-RNO-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-RNO-8957275; Post-translational protein phosphorylation.
DR   PRO; PR:Q63772; -.
DR   Proteomes; UP000002494; Chromosome 16.
DR   Bgee; ENSRNOG00000018233; Expressed in lung and 19 other cell types or tissues.
DR   ExpressionAtlas; Q63772; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0043027; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; ISS:UniProtKB.
DR   GO; GO:0008083; F:growth factor activity; TAS:RGD.
DR   GO; GO:0001786; F:phosphatidylserine binding; ISS:UniProtKB.
DR   GO; GO:0030674; F:protein-macromolecule adaptor activity; ISS:UniProtKB.
DR   GO; GO:0048018; F:receptor ligand activity; ISS:UniProtKB.
DR   GO; GO:0030971; F:receptor tyrosine kinase binding; ISO:RGD.
DR   GO; GO:0005102; F:signaling receptor binding; ISS:UniProtKB.
DR   GO; GO:0032148; P:activation of protein kinase B activity; IDA:UniProtKB.
DR   GO; GO:0031100; P:animal organ regeneration; IEP:RGD.
DR   GO; GO:0043277; P:apoptotic cell clearance; ISS:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; ISO:RGD.
DR   GO; GO:0035754; P:B cell chemotaxis; ISS:UniProtKB.
DR   GO; GO:0007596; P:blood coagulation; ISO:RGD.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; ISO:RGD.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; ISO:RGD.
DR   GO; GO:0031589; P:cell-substrate adhesion; ISO:RGD.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; IDA:UniProtKB.
DR   GO; GO:0071363; P:cellular response to growth factor stimulus; ISO:RGD.
DR   GO; GO:0035457; P:cellular response to interferon-alpha; ISS:UniProtKB.
DR   GO; GO:0009267; P:cellular response to starvation; ISO:RGD.
DR   GO; GO:0071307; P:cellular response to vitamin K; ISS:UniProtKB.
DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; IDA:UniProtKB.
DR   GO; GO:0097028; P:dendritic cell differentiation; ISO:RGD.
DR   GO; GO:0007167; P:enzyme-linked receptor protein signaling pathway; ISO:RGD.
DR   GO; GO:0085029; P:extracellular matrix assembly; IEP:UniProtKB.
DR   GO; GO:0044346; P:fibroblast apoptotic process; ISO:RGD.
DR   GO; GO:0019064; P:fusion of virus membrane with host plasma membrane; ISS:UniProtKB.
DR   GO; GO:0097241; P:hematopoietic stem cell migration to bone marrow; ISS:UniProtKB.
DR   GO; GO:0033028; P:myeloid cell apoptotic process; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISO:RGD.
DR   GO; GO:0070168; P:negative regulation of biomineral tissue development; ISS:UniProtKB.
DR   GO; GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; ISS:UniProtKB.
DR   GO; GO:2000669; P:negative regulation of dendritic cell apoptotic process; ISS:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:2000352; P:negative regulation of endothelial cell apoptotic process; ISS:UniProtKB.
DR   GO; GO:2000270; P:negative regulation of fibroblast apoptotic process; ISS:UniProtKB.
DR   GO; GO:0032692; P:negative regulation of interleukin-1 production; ISS:UniProtKB.
DR   GO; GO:0032715; P:negative regulation of interleukin-6 production; ISS:UniProtKB.
DR   GO; GO:0033033; P:negative regulation of myeloid cell apoptotic process; ISO:RGD.
DR   GO; GO:1900142; P:negative regulation of oligodendrocyte apoptotic process; ISS:UniProtKB.
DR   GO; GO:2000533; P:negative regulation of renal albumin absorption; IEP:UniProtKB.
DR   GO; GO:0032720; P:negative regulation of tumor necrosis factor production; ISS:UniProtKB.
DR   GO; GO:0010804; P:negative regulation of tumor necrosis factor-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0032689; P:negative regulation of type II interferon production; ISS:UniProtKB.
DR   GO; GO:0001764; P:neuron migration; ISO:RGD.
DR   GO; GO:0006909; P:phagocytosis; ISS:UniProtKB.
DR   GO; GO:0001961; P:positive regulation of cytokine-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:2000510; P:positive regulation of dendritic cell chemotaxis; ISO:RGD.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISO:RGD.
DR   GO; GO:0048146; P:positive regulation of fibroblast proliferation; ISS:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0003104; P:positive regulation of glomerular filtration; IDA:UniProtKB.
DR   GO; GO:0032825; P:positive regulation of natural killer cell differentiation; ISS:UniProtKB.
DR   GO; GO:0050766; P:positive regulation of phagocytosis; ISS:UniProtKB.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; IDA:UniProtKB.
DR   GO; GO:0046827; P:positive regulation of protein export from nucleus; ISS:UniProtKB.
DR   GO; GO:0045860; P:positive regulation of protein kinase activity; ISS:UniProtKB.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0032008; P:positive regulation of TOR signaling; IDA:UniProtKB.
DR   GO; GO:0072659; P:protein localization to plasma membrane; ISS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:0046813; P:receptor-mediated virion attachment to host cell; ISS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; IDA:UniProtKB.
DR   GO; GO:0046718; P:symbiont entry into host cell; ISS:UniProtKB.
DR   GO; GO:0042246; P:tissue regeneration; TAS:RGD.
DR   GO; GO:0048771; P:tissue remodeling; TAS:RGD.
DR   GO; GO:0019079; P:viral genome replication; ISS:UniProtKB.
DR   CDD; cd00054; EGF_CA; 1.
DR   CDD; cd00110; LamG; 2.
DR   Gene3D; 2.60.120.200; -; 2.
DR   Gene3D; 4.10.740.10; Coagulation Factor IX; 1.
DR   Gene3D; 2.10.25.10; Laminin; 4.
DR   InterPro; IPR017857; Coagulation_fac-like_Gla_dom.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR051145; GAS-SHBG-PROS.
DR   InterPro; IPR035972; GLA-like_dom_SF.
DR   InterPro; IPR000294; GLA_domain.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR001791; Laminin_G.
DR   InterPro; IPR049883; NOTCH1_EGF-like.
DR   PANTHER; PTHR24040:SF14; GROWTH ARREST-SPECIFIC PROTEIN 6; 1.
DR   PANTHER; PTHR24040; LAMININ G-LIKE DOMAIN-CONTAINING PROTEIN; 1.
DR   Pfam; PF07645; EGF_CA; 2.
DR   Pfam; PF14670; FXa_inhibition; 1.
DR   Pfam; PF00594; Gla; 1.
DR   Pfam; PF00054; Laminin_G_1; 1.
DR   Pfam; PF02210; Laminin_G_2; 1.
DR   PRINTS; PR00001; GLABLOOD.
DR   SMART; SM00181; EGF; 4.
DR   SMART; SM00179; EGF_CA; 4.
DR   SMART; SM00069; GLA; 1.
DR   SMART; SM00282; LamG; 2.
DR   SUPFAM; SSF49899; Concanavalin A-like lectins/glucanases; 2.
DR   SUPFAM; SSF57196; EGF/Laminin; 1.
DR   SUPFAM; SSF57630; GLA-domain; 1.
DR   SUPFAM; SSF57184; Growth factor receptor domain; 1.
DR   PROSITE; PS00010; ASX_HYDROXYL; 4.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS01186; EGF_2; 3.
DR   PROSITE; PS50026; EGF_3; 4.
DR   PROSITE; PS01187; EGF_CA; 3.
DR   PROSITE; PS00011; GLA_1; 1.
DR   PROSITE; PS50998; GLA_2; 1.
DR   PROSITE; PS50025; LAM_G_DOMAIN; 2.
PE   1: Evidence at protein level;
KW   Calcium; Disulfide bond; EGF-like domain; Gamma-carboxyglutamic acid;
KW   Glycoprotein; Growth regulation; Metal-binding; Phosphoprotein;
KW   Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL          1..27
FT                   /evidence="ECO:0000255"
FT   CHAIN           28..674
FT                   /note="Growth arrest-specific protein 6"
FT                   /id="PRO_0000007591"
FT   DOMAIN          50..91
FT                   /note="Gla"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00463"
FT   DOMAIN          113..151
FT                   /note="EGF-like 1; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          153..193
FT                   /note="EGF-like 2; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          194..234
FT                   /note="EGF-like 3; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          235..275
FT                   /note="EGF-like 4; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          295..467
FT                   /note="Laminin G-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00122"
FT   DOMAIN          474..666
FT                   /note="Laminin G-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00122"
FT   BINDING         326
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         328
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         437
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         652
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         68
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14393"
FT   MOD_RES         609
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   MOD_RES         614
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   MOD_RES         617
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   MOD_RES         633
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   MOD_RES         636
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   CARBOHYD        189
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        417
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        488
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        62..67
FT                   /evidence="ECO:0000250"
FT   DISULFID        117..130
FT                   /evidence="ECO:0000250"
FT   DISULFID        122..139
FT                   /evidence="ECO:0000250"
FT   DISULFID        141..150
FT                   /evidence="ECO:0000250"
FT   DISULFID        157..168
FT                   /evidence="ECO:0000250"
FT   DISULFID        164..177
FT                   /evidence="ECO:0000250"
FT   DISULFID        179..192
FT                   /evidence="ECO:0000250"
FT   DISULFID        198..209
FT                   /evidence="ECO:0000250"
FT   DISULFID        204..218
FT                   /evidence="ECO:0000250"
FT   DISULFID        220..233
FT                   /evidence="ECO:0000250"
FT   DISULFID        239..248
FT                   /evidence="ECO:0000250"
FT   DISULFID        244..257
FT                   /evidence="ECO:0000250"
FT   DISULFID        259..274
FT                   /evidence="ECO:0000250"
FT   DISULFID        280..566
FT                   /evidence="ECO:0000250"
FT   DISULFID        441..467
FT                   /evidence="ECO:0000250"
FT   DISULFID        639..666
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   674 AA;  74638 MW;  FBF8F6B8664D6F2E CRC64;
     MPPPPGPTAA LGTALLLLLL ASESSHTVLL RAREAAQFLR PRQRRAYQVF EEAKQGHLER
     ECVEEVCSKE EAREVFENDP ETDYFYPRYQ ECMRKYGRPE DKNPNFATCV KNLPDQCTPN
     PCDKKGTQLC QDLMGNFFCL CKDGWGGRLC DKDVNECSQK NGGCSQVCHN KPGSFQCACH
     SGFSLQSDNK SCQDIDECTD SDTCGDARCK NLPGSYSCLC DKGYTYSSKE KTCQDVDECQ
     QDRCEQTCVN SPGSYTCHCN GRGGLKLSPD MDTCEDILPC VPFSMAKSVK SLYLGRMFSG
     TPVIRLRFKR LQPTRLLAEF DFRTFDPEGV LFFAGGRSDS TWIVLGLRAG RLELQLRYNG
     VGRITSSGPT INHGMWQTIS VEELDRNLVI KVNKDAVMKI AVAGGLFQLE RGLYHLNLTV
     GGIPFKESDL VQPINPRLDG CMRSWNWLNG EDSAIQETVK ANTKMQCFSV TERGSFFPGN
     GFAFYSLNYT RTSLDVGTET TWEVEVVARI RPATDTGVLM ALVGDKDVVL LSVALVDYHS
     TKKLKKQLVV LAVENVALAL MEIKVCDSQE HTVTVSLRDG EATLEVDGTK GQSEVSTAQL
     QERLDLLKTR LQGSVLTFVG GLPDVQVTST PVTAFYRGCM TLEVNGKTLD LDTASYKHSD
     ITSHSCPPVE HVTA
//
